Induction of Labour at Term With Low Dose Oral Misoprostol Versus a Foley Catheter
NCT ID: NCT06056141
Last Updated: 2025-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
300 participants
INTERVENTIONAL
2023-10-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sequential Use of Foley's Catheter and Misoprostol Versus Misoprostol Alone for Induction of Labour: a Multicentre Randomised Controlled Trial
NCT06249815
Vaginal Misoprostol With Intracervical Foley Catheter in Induction of Labor
NCT03682718
Failure of Vaginal Delivery After Induction
NCT02758340
Vaginal Misoprostol and Foley Catheter for Induction of Labor
NCT02952807
Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women
NCT05696574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Drug: Misoprostol 25mcg (200 mcg dissolved with 200 ml water and divided to 8 doses) every 2 hours
Misoprostol 200mcg Tab
Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
Group B
Device: Foley Catheter Transcervical Foley catheter (silicone, size 20F with 30ml balloon)
Foley Catheter
Transcervical Foley catheter (silicone, size 20F with 30ml balloon)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol 200mcg Tab
Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
Foley Catheter
Transcervical Foley catheter (silicone, size 20F with 30ml balloon)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asfendiyarov Kazakh National Medical University
OTHER
Kazakhstan's Medical University "KSPH"
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilfuza Sultanmuratova
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City Perinatology Centre 3
Almaty, , Kazakhstan
Center for Perinatology and Pediatric Cardiac Surgery
Almaty, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-23-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.